Growth Metrics

Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (Diluted Average) (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Shares Outstanding (Diluted Average) readings, the most recent being $11.6 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 8.39% to $11.6 billion in Q1 2026 year-over-year; TTM through Feb 2026 was $11.6 billion, a 8.39% increase, with the full-year FY2025 number at $10.7 billion, up 3.86% from a year prior.
  • Shares Outstanding (Diluted Average) reached $11.6 billion in Q1 2026 per CBIH's latest filing, roughly flat from $11.6 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $11.6 billion in Q3 2025, with the low at $7.9 billion in Q1 2023.
  • A 5-year average of $10.3 billion and a median of $10.4 billion in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Peak annual rise in Shares Outstanding (Diluted Average) hit 31.99% in 2024, while the deepest fall reached 1.23% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $8.8 billion in 2022, then grew by 17.61% to $10.3 billion in 2023, then grew by 1.6% to $10.5 billion in 2024, then grew by 10.76% to $11.6 billion in 2025, then changed by 0.0% to $11.6 billion in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Shares Outstanding (Diluted Average) are $11.6 billion (Q1 2026), $11.6 billion (Q4 2025), and $11.6 billion (Q3 2025).